Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clotet

Showing results (201-210 of 263) with videos related to

Pageof 27
Sort By:
AIDS Research and Human Retroviruses|December 2, 1999
Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4C Cabrera, M Witvrouw, A Gutiérrez, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 10, 1998
Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patientsL Ruiz, M Nijhuis, C Boucher, et al.
HIV Medicine|April 27, 2011
Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)Daniel Podzamczer, J Andrade-Villanueva, B Clotet, et al.
AIDS (London, England)|August 28, 1999
Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replicationF García, G Niebla, J Romeu, et al.
Journal of Viral Hepatitis|November 4, 2014
Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in SpainS Serrano-Villar, P Sobrino-Vegas, S Monge, et al.
Antiviral Therapy|April 1, 1997
Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3A Ibáñez, J Peraire, A Arnó, et al.
Journal of Virological Methods|August 15, 1998
Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutationsJ C Schmit, L Ruiz, L Stuyver, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled studyL Ruiz, E Negredo, P Domingo, et al.
Molecular Pharmacology|March 14, 1998
Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)J A Esté, C Cabrera, D Schols, et al.
AIDS (London, England)|March 9, 2000
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimenJ L Casado, K Hertogs, L Ruiz, et al.
Pageof 27

Showing results (201-210 of 263) with videos related to

Sort By:
Pageof 27
AIDS Research and Human Retroviruses|December 2, 1999
Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4C Cabrera, M Witvrouw, A Gutiérrez, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 10, 1998
Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patientsL Ruiz, M Nijhuis, C Boucher, et al.
HIV Medicine|April 27, 2011
Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)Daniel Podzamczer, J Andrade-Villanueva, B Clotet, et al.
AIDS (London, England)|August 28, 1999
Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replicationF García, G Niebla, J Romeu, et al.
Journal of Viral Hepatitis|November 4, 2014
Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in SpainS Serrano-Villar, P Sobrino-Vegas, S Monge, et al.
Antiviral Therapy|April 1, 1997
Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3A Ibáñez, J Peraire, A Arnó, et al.
Journal of Virological Methods|August 15, 1998
Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutationsJ C Schmit, L Ruiz, L Stuyver, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled studyL Ruiz, E Negredo, P Domingo, et al.
Molecular Pharmacology|March 14, 1998
Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)J A Esté, C Cabrera, D Schols, et al.
AIDS (London, England)|March 9, 2000
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimenJ L Casado, K Hertogs, L Ruiz, et al.
Pageof 27